Altria reported a net revenue increase of 4.9% to $6.304 billion and a diluted EPS of $1.03 for Q4 2020. The company is focusing on accelerating investments to support its 10-year vision and expects full-year adjusted diluted EPS to grow by 3% to 6% in 2021.
Net revenues increased by 4.9% driven by higher revenues in the smokeable products segment.
Reported diluted EPS increased 100%+ to $1.03, driven by 2019 impairment of JUUL equity securities and higher reported OCI in the smokeable products and oral tobacco products segments.
Adjusted diluted EPS decreased 2.0% to $0.99, driven by adjusted losses in the all other category and lower adjusted earnings from Altria’s investment in ABI.
A new $2 billion share repurchase program was authorized, expected to be completed by June 30, 2022.
Altria expects its 2021 full-year adjusted diluted EPS to be in a range of $4.49 to $4.62, representing a growth rate of 3% to 6% from an adjusted diluted EPS base of $4.36 in 2020.
Visualization of income flow from segment revenue to net income